Clinical Trial Update: Dysport® Pediatric Lower Limb Spasticity Follow-on Study [Phase 3]

View source ↗

Summary

Phase 3 follow-on study for Dysport in pediatric lower limb spasticity due to cerebral palsy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Muscle Spasticity

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Cerebral Palsy, Muscle Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2017-06-01